Article Information
Published By
Online ISSN
History
- Received July 11, 2022
- Accepted October 4, 2022
- Published online October 13, 2022.
Article Versions
- You are currently viewing a previous version of this article (October 13, 2022 - 06:04).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Dirk van Lier1,2,
- Benjamin Deniau3,4,
- Karine Santos5,
- Oliver Hartmann5,6,
- Emmanuel Dudoignon3,4,
- François Depret3,4,
- Benoit Plaud3,4,
- Pierre-Francois Laterre7,
- Alexandre Mebazaa3 and
- Peter Pickkers1,2⇑
- 1Radboud University Medical Center, Department Intensive Care, Nijmegen, The Netherlands
- 2Radboud University Medical Center, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
- 3Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France
- 4Université de Paris Cité, Paris, France
- 54TEEN4 Pharmaceuticals GmbH, Hennigsdorf/Berlin, Germany
- 6Sphingotec GmbH, Hennigsdorf/Berlin, Germany
- 7Cliniques Universitaires Saint-Luc, (UCL Bruxelles), Avenue Hippocrate 10, 1200, Brussels, Belgium
- Peter Pickkers, Radboud University Medical Center, Department Intensive Care, Nijmegen, The Netherlands. E-mail: Peter.Pickkers{at}radboudumc.nl
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study
